UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006510
Receipt number R000007724
Scientific Title A randomized controlled trial of neck dissections based on sentinel lymph node navigation versus standard selective neck dissections in N0 oral cancers
Date of disclosure of the study information 2011/10/17
Last modified on 2020/10/20 09:27:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized controlled trial of neck dissections based on sentinel lymph node navigation versus standard selective neck dissections in N0 oral cancers

Acronym

RCT of sentinel lymph node navigation surgery in oral cancers

Scientific Title

A randomized controlled trial of neck dissections based on sentinel lymph node navigation versus standard selective neck dissections in N0 oral cancers

Scientific Title:Acronym

RCT of sentinel lymph node navigation surgery in oral cancers

Region

Japan


Condition

Condition

Oral Cancer

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The objective of the study is to evaluate the non-Inferiority of survival and, the superiority of postoperative disability and complication of the neck in neck dissections based on sentinel lymph node navigation in N0 oral cancer patients, compared with standard selective neck dissections.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

3 years overall survival

Key secondary outcomes

1)postoperative functional disability and complication of neck
2)3 years disease free survival
3)contralateral neck recurrence and false negative rate
4)accuracy of detecting of sentinel nodes and intraoperative diagnoses of their status


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Selective neck dissections based on sentinel lymph node navigation

Interventions/Control_2

Standard selective neck dissections

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Previously untreated and clinically negative neck oral squamous cell carcinoma patients (late T1 and T3) are the candidates for our study.

Key exclusion criteria

1)Previously treated patients
2)A history of radiation therapy for the neck
3)Pregnancy or lactating women, or women with suspected pregnancy
4)Patients judged by the investigator to be unfit to be enrolled into the study

Target sample size

256


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuhisa Hasegawa

Organization

Aichi Cancer Center

Division name

Department of Head and Neck Surgery

Zip code


Address

1-1 Kanokoden Chikusaku, Nagoya 464-8681, Japan

TEL

052-764-2944

Email

hasegawa@aichi-cc.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasuhisa Hasegawa

Organization

Aichi Cancer Center

Division name

Department of Head and Neck Surgery

Zip code


Address

1-1 Kanokoden Chikusaku, Nagoya 464-8681, Japan

TEL

052-762-6111

Homepage URL


Email

hasegawa@aichi-cc.jp


Sponsor or person

Institute

Aichi Cancer Center

Institute

Department

Personal name



Funding Source

Organization

Health and Labor Sciences Research Grant for Clinical Cancer Research (H21-Gannorinshou-Ippan-016)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 10 Month 17 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

275

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 07 Month 19 Day

Date of IRB

2011 Year 09 Month 02 Day

Anticipated trial start date

2011 Year 11 Month 26 Day

Last follow-up date

2019 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 10 Month 10 Day

Last modified on

2020 Year 10 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007724


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name